Concept: Research decentralisation

clinical trial participation should be widely accessible by advancing policies, research practices and new technologies in decentralized clinical research (Ripton, J 2021)


More engagement & participation

Short time anticipated to complete the research

Very useful for rare or infrequent diseases

Authorship Can be up to 100 researchers


Research topics must be feasible for researchers with different circumstances (difficult to achieve)

Difficult monitoring the methodology

Probability of fabrication or data falsification can not be ignored

Threatens the institutional research


Powerful plateform for researchers all over the world

Need close monitoring of data set for each research

Selection of feasible topics